NRx Pharmaceuticals Inc (NRXPW) — Financial Flexibility Index
NRx Pharmaceuticals Inc (NRXPW) has a Financial Flexibility Index of -0.17x as of March 2026. Free cash flow of $-4.29 Million (operating CF $-4.29 Million minus capex $0.00) represents 0% of total liabilities ($25.72 Million). Check NRXPW asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NRx Pharmaceuticals Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for NRx Pharmaceuticals Inc across 9 annual periods. See NRx Pharmaceuticals Inc (NRXPW) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for NRx Pharmaceuticals Inc (2017–2025)
Year-by-year free cash flow to debt coverage for NRx Pharmaceuticals Inc. For the full company profile including market capitalisation, see market cap of NRx Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.49x | $-14.11 Million | $-14.11 Million | $28.89 Million | ▼ -23.4% |
| 2024 | -0.40x | $-10.64 Million | $-10.64 Million | $26.87 Million | ▲ +65.2% |
| 2023 | -1.14x | $-21.65 Million | $-21.66 Million | $19.05 Million | ▲ +47.4% |
| 2022 | -2.16x | $-39.74 Million | $-39.76 Million | $18.41 Million | ▲ +31.7% |
| 2021 | -3.16x | $-37.70 Million | $-37.70 Million | $11.92 Million | ▼ -6426.1% |
| 2020 | -0.05x | $-2.26 Million | $-2.27 Million | $46.71 Million | ▲ +84.3% |
| 2019 | -0.31x | $-792.73K | $-792.73K | $2.57 Million | ▲ +18.2% |
| 2018 | -0.38x | $-473.19K | $-473.19K | $1.26 Million | ▲ +74.2% |
| 2017 | -1.46x | $-135.81K | $-135.81K | $93.17K | — |